The U.S. Food and Drug Administration approved the medication lecanemab, sold under the brand name Leqembi, on Jan. 6, 2023, through an "accelerated approval pathway" that fast-tracks promising clinical treatments for diseases ...
Jan 16, 2023
0
9
Researchers have found that a class of older antipsychotic drugs could be a promising new therapeutic option for people with type 2 diabetes, helping fill a need among patients who aren't able to take other currently available ...
Jan 13, 2023
0
117
US public health officials this week authorized pharmacies to sell abortion pills by prescription. What exactly does that change for women in the United States, after several states banned abortion last year?
Jan 8, 2023
0
3
Germany will pay up to 50 percent more for common children's medication such as cough syrup and fever drugs to combat a severe shortage this winter, the health minister said Tuesday.
Dec 20, 2022
0
1
Europe and North America have seen shortages of the key antibiotic amoxicillin and other medications as surging illnesses particularly among children have increased demand for the drugs.
Dec 20, 2022
0
15
In the competition between brand name pharmaceuticals and their generic counterparts, drug companies use patent gamesmanship to their advantage, one West Virginia University patent expert said.
Dec 19, 2022
0
3
A large team of researchers at Emulate Inc., working with colleagues from several institutions in the U.S., has found that human liver-chips are showing promise as a predictive toxicology tool. In their paper published in ...
While a "tripledemic" of RSV, flu and COVID-19 continue to strain health care systems across Texas and the U.S., drug shortages are also complicating patient care during this year's severe respiratory virus season.
Dec 13, 2022
0
18
Researchers from the University at Buffalo School of Pharmacy and Pharmaceutical Sciences recently published in Molecular & Cellular Proteomics, describing their work in identifying key metabolic regulators involved in cancer ...
Dec 13, 2022
0
40
Drug companies must make fundamental changes to their core business to address R&D gaps and access to existing medicines for women's sexual and reproductive health in lower-income countries, global health equity advocates ...
Dec 12, 2022
0
14
